Descriptors
Documents disponibles dans cette catégorie (453)
Add the result to your basket Make a suggestion Refine your search Apply to external sources
Extend search on down-posting(s)
Drug reimbursement systems / Maïté le Polain / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2010)
Drug reimbursement systems : international comparison and policy recommendations [printed text] / Maïté le Polain, Author ; Margreet Franken, Author ; Marc Koopmanschap, Author ; Irina Cleemput , Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2010 . - VIII, 151 p. : ill. ; A4. - (KCE Reports. Health Services Research (HSR); 147C) .
€ 0,00
Languages : English (eng)
Descriptors: Classification
QV 736 Drug industry. Economics of pharmacy. Advertising
Indexation
2009-19 ; Advisory Committees ; Decision Making ; Economics, Pharmaceutical ; Insurance, Health, Reimbursement ; Policy Making ; R147Contents note: LIST OF ABBREVIATIONS 3 -- 1 INTRODUCTION 5 -- 1.1 BACKGROUND 5 -- 1.2 OBJECTIVES 6 -- 1.3 METHODS AND ANALYTICAL FRAMEWORKS 6 -- 1.3.1 The description of the drug reimbursement systems 6 -- 1.3.2 Assessing accountability for reasonableness 8 -- 1.4 KEY CONCEPTS 9 -- 1.5 STRUCTURE OF THE REPORT 10 -- 2 COUNTRY COMPARISON 12 -- 2.1 CONTEXTUAL BACKGROUND 12 -- 2.1.1 Health care system characteristics 12 -- 2.1.2 Health care system and policy objectives 12 -- 2.1.3 Health care funding and pharmaceutical expenditure 13 -- 2.1.4 Pharmaceutical policies 15 -- 2.2 POLICY IMPLEMENTATION LEVEL 18 -- 2.2.1 Objectives of the drug reimbursement system. 18 -- 2.2.2 Establishment of the system 19 -- 2.2.3 Implementation: a positive reimbursement list 24 -- 2.2.4 Accountability: impact assessment 24 -- 2.3 TECHNOLOGY DECISION LEVEL 26 -- 2.3.1 Assessment and appraisal phase 26 -- 2.3.2 Decision making phase 32 -- 2.3.3 Output and Implementation 36 -- 3 DISCUSSION 39 -- 3.1 ACCOUNTABILITY FOR REASONABLENESS 39 -- 3.1.1 Transparency 40 -- 3.1.2 Relevance of the decision rationales 41 -- 3.1.3 Relevance of the decision criteria 41 -- 3.1.4 Relevance of decision criteria: summarising countries’ achievements 52 -- 3.1.5 Revisability 53 -- 3.1.6 Enforcement 53 -- 4 GENERAL CONCLUSIONS AND RECOMMENDATIONS 55 -- 4.1 TRANSPARENCY CONDITION 55 -- 4.2 RELEVANCE CONDITION 56 -- 4.3 REVISABILITY CONDITION 57 -- 4.4 ENFORCEMENT CONDITION 57 -- 4.5 FUTURE RESEARCH 57 -- 5 LESSONS FOR BELGIUM 60 -- 5.1 ROLES OF THE DIFFERENT ACTORS IN THE PROCESS 60 -- 5.2 STRENGTHS OF THE BELGIAN REIMBURSEMENT SYSTEM 61 -- 5.3 ISSUES RELATED TO THE DECISION PROCESS 61 -- 5.3.1 Composition of the CRM/CTG 61 -- 5.3.2 Assessment by the RIZIV/INAMI experts 62 -- 5.3.3 Appraisal by the Drug Reimbursement Committee (CRM/CTG) 63 -- 5.3.4 Price and reimbursement basis 64 -- 5.3.5 Reimbursement category 65 -- 5.3.6 Decision by the Minister 66 -- 5.4 DISCUSSION 67 -- 5.4.1 Transparency 67 -- 5.4.2 Relevance of the appraisal criteria 68 -- 5.4.3 Revisions 68 -- 5.5 CONCLUSION 68 -- 6 APPENDICES 69 -- DRUG REIMBURSEMENT SYSTEM IN AUSTRIA 69 -- DRUG REIMBURSEMENT SYSTEM IN BELGIUM 81 -- DRUG REIMBURSEMENT SYSTEM IN FRANCE 99 -- DRUG REIMBURSEMENT SYSTEM IN THE NETHERLANDS 114 -- DRUG REIMBURSEMENT SYSTEM IN SWEDEN 128 -- 7 REFERENCES 143 Link for e-copy: https://doi.org/10.57598/R147C Format of e-copy: PDF (1,2 Mb) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2300 Copies(0)
Status No copy Dynamic HTML / Danny Goodman / Sebastopol : O'Reilly (2002)
Dynamic HTML : the definitive reference [printed text] / Danny Goodman, Author . - 2nd ed. . - Sebastopol : O'Reilly, 2002 . - 1 vol. (xiii-1401 p.) : ill. ; 24 cm.
ISBN : 978-0-596-00316-6 : 64,41 EUR
Languages : English (eng)
Descriptors: Classification
QA 76.755 - Computer Software. Handbook
Indexation
Handbooks ; HTML (Document markup language)Abstract: Dynamic HTML: The Definitive Reference, 2nd Edition, is an indispensable compendium for web development. The new edition has been updated to include complete reference material on the latest specifications, including HTML 4.01, CSS Level 2, DOM Level 2, and JavaScript 1.5, as well as the latest browsers, Internet Explorer 6 (Windows), Internet Explorer 5.1 (Mac), Netscape Navigator 6 and 7, and Mozilla 1.0. Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1890 Hold
Place a hold on this item
Copies(1)
Barcode Call number Media type Location Section Status 10273-01939 QA 76.755 /GOO Book KCE Library (10.124) Available
e-COMPENDIUM [electronic document] . - Brussel [Belgium] : Pharma.be, 2008.
Mise à jour Quotidienne
Languages : French (fre)
Descriptors: Classification
QV 13 Pharmacology. Dictionaries. Encyclopedias
Indexation
Databases, Web ; Dictionaries, Pharmaceutic ; Dose-Response Relationship, Drug ; Pharmaceutical PreparationsContents note: * Les notices scientifiques originales des médicaments à usage humain et Vétérinaire.
* Les résumés des notices scientifiques, rédigés en collaboration avec l'Ecole de Santé Publique de l'Université Libre de Bruxelles (ULB).
* Le prix et des informations de remboursement actuel des medicaments.Link for e-copy: http://www.e-compendium.be/ Format of e-copy: Online Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1823
e-COMPENDIUM [electronic document] . - Brussel [Belgium] : Pharma.be, 2008.
dagelijk update
Languages : Dutch (dut)
Descriptors: Classification
QV 13 Pharmacology. Dictionaries. Encyclopedias
Indexation
Databases, Web ; Dictionaries, Pharmaceutic ; Dose-Response Relationship, Drug ; Pharmaceutical PreparationsContents note: * De originele wetenschappelijke bijsluiters van geneesmiddelen voor humaan en diergeneeskundig gebruik.
* Samenvattingen van de wetenschappelijke bijsluiters, opgesteld i.s.m. de Ecole de Santé Publique van de Université Libre de Bruxelles (ULB).
* Actuele prijs-en terugbetalingsinformatie van de geneesmiddelen.
Link for e-copy: http://www.e-compendium.be/ Format of e-copy: Online Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1824 Economic evaluation in clinical trials / Henry Glick / Oxford ; Melbourne ; New York : Oxford University Press - OUP (2007)
Economic evaluation in clinical trials [printed text] / Henry Glick, Author ; Jalpa A. Doshi ; Seema S. Sonnad ; Daniel Polsky . - Oxford University Press, 2007 . - x, 244 p. : ill. - (Handbooks in health economic evaluation series) .
ISBN : 978-0-19-852997-2 : € 38,18
Languages : English (eng)
Descriptors: Classification
QV 771 Standardization and evaluation of drugs
Indexation
Clinical Trials ; Cost-Benefit Analysis ; Economics ; Outcome Assessment (Health Care)Abstract: * Hugely important for anyone involved in the development of new drugs, therapies, or devices
* Supporting material provided online
* A practical guide to teach the reader how to design and conduct appropriate, rigorous economic evaluations of clinical trials
It is becoming increasingly important to examine the relationship between the outcomes of a clinical trial and the costs of the medical therapy under study. The results of such analysis can affect reimbursement decisions for new medical technologies, for example drugs, devices or diagnostics; aid companies seeking to make claims about the cost-effectiveness of their product; allow early consideration of the economic value of therapies, which may be important to improving initial adoption decisions; or address the requirements of regulatory bodies. Economic evaluation in clinical trials uses a consistent set of data collected within the trial, or by projection from this data, and avoids having to incorporate unrelated (and potentially inconsistent) data from many different sources.
This book provides a practical guide to conducting economic evaluation in ongoing clinical trials. It covers issues and techniques related to the collection of both cost and outcome data, as well as a framework for reporting and interpreting economic reports from clinical trials. This is illustrated by detailed supporting examples and exercises, designed to teach the reader how to apply this model. These exercises are supported with datasets, programmes and solutions made available online.
Readership: This book will be invaluable to students of health economics studying economic assessment methods; investigators working on economic analysis in clinical trials will find practical advice concerning the design and analysis of such studies; those in industry and government who fund clinical trials, and are interested in the claims regarding cost-effectiveness, will find useful information to determine whether the proposed studies are methodologically sound.Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=858 Hold
Place a hold on this item
Copies(1)
Barcode Call number Media type Location Section Status 10273-00970 QV 771/GLI Book KCE Library (10.124) Due for return by 03/31/2016 Readers who borrowed this document also borrowed:
Concepts of epidemiology Bhopal, Raj S. Base SAS 9.1.3 Procedures Guide The Ethics of Screening in Health Care and Medicine Juth, Niklas Health statistics Friedman, Daniel J. Designing and conducting cost-effectiveness analyses in medicine and health care Muennig, Peter Quality of life and pharmacoeconomics Cramer, Joyce A. Models for discrete data Zelterman, Daniel Decision Modelling for Health Economic Evaluation Briggs, Andrew H. Cost-effectiveness analysis Levin, Henry M. (1938-....) A dictionary of epidemiology Porta, Miquel S., International Epidemiological Association Cost-effectiveness in health and medicine Gold, Marthe R. Economic evaluation of vaccination programmes in human / Philippe Beutels / Antwerpen [Belgium] : Universiteit Antwerpen (UA) (2002)
PermalinkEen kritische kijk op het kankerbeleid / Vlaamse Liga tegen Kanker, VLK (Koningsstraat 217, Brussel, België) / Brussel [Belgë] : Vlaamse Liga tegen Kanker, VLK (2008)
PermalinkEen kritische kijk op het kankerbeleid / Vlaamse Liga tegen Kanker, VLK (Koningsstraat 217, Brussel, België) / Brussel [Belgë] : Vlaamse Liga tegen Kanker, VLK (2009)
PermalinkEen kritische kijk op het kankerbeleid / Vlaamse Liga tegen Kanker, VLK (Koningsstraat 217, Brussel, België) / Brussel [Belgë] : Vlaamse Liga tegen Kanker, VLK (2010)
PermalinkEncyclopaedia anatomica / Monika von Düring / Köln : Taschen (1999)
PermalinkPermalinkEndNote / Thomson ResearchSoft / Thomson (2003)
PermalinkEndocrine System and Selected Metabolic Diseases / Frank H. Netter / Summit, N. J. : Ciba Pharmaceutical Products (1981)
PermalinkPermalinkEnsuring Quality Cancer Care / Thomas Smith / Richmond [U.S.A.] : Virginia Commonwealth University (1998)
PermalinkEPARs for authorised medicinal products for human use / London [UK] : European Medicines Agency (EMEA) (2009)
PermalinkEpigénétique et mémoire cellulaire / Edith Heard / Fayard (2013)
PermalinkLes épistémologies constructivistes / Jean-Louis Le Moigne / Paris : Presses universitaires de France (PUF) (2007)
PermalinkERP & Accountancy Guide 2006 / Kurt Focquaert / Vilvoorde [Belgium] : VNU Business Publications (2006)
PermalinkEssential statistics for the pharmaceutical sciences / Philip Rowe / Chichester : John Wiley & Sons (2007)
PermalinkPermalinkEuropean Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) / European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) / London [UK] : European Medicines Agency (EMEA) (2006)
PermalinkEuropean Network of Centres for Pharmacoepidemiology and Pharmacovigilance / European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) / London [UK] : European Medicines Agency (EMEA) (2006)
PermalinkEvaluatierapporten CTG / Commissie tegemoetkoming geneesmiddelen (CTG) = Commission de Remboursement des Médicaments (CRM) / Bruxelles [Belgium] : Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) = Institut National Maladie Invalidité (INAMI) (2008)
PermalinkEvidence-based inhoud van geschreven informatie vanuit de farmaceutische industrie aan huisartsen / Annelies Van Linden / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2007)
PermalinkEviter les effets indésirables par interactions médicamenteuses / Elisabeth Veyriac / Paris : Association Mieux Prescrire (2011)
PermalinkExploring the impact of medication information for psychiatric patients at hospital discharge / Franciska Desplenter / Leuven [Belgium] : Katholieke Universiteit Leuven (KUL) (2009)
PermalinkPermalinkFarmacotherapeutisch kompas 2002 / A.C. van Loenen / College voor zorgverzekering (CVZ) (2002)
PermalinkFlow chart pharmaceutical system (IN- & OUT- patient sector) / Bruxelles [Belgium] : Rijksinstituut voor Ziekte- en Invaliditeitsverzekering (RIZIV) = Institut National Maladie Invalidité (INAMI) (2010)
PermalinkFormulaire des médicaments / Bruxelles [Belgique] : FOD Justitie = SPF Justice (2014)
PermalinkFreins et leviers à l’adoption des médicaments biosimilaires en Belgique / Isabelle Lepage-Nefkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2013)
PermalinkFuture scenarios about drug development and drug pricing / Philippe Vandenbroeck / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2016)
PermalinkFuture scenarios about drug development and drug pricing / Philippe Vandenbroeck / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2016)
PermalinkGebruik van point-of care systemen bij patiënten met orale anticoagulatie / Jeannine Gailly / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2009)
PermalinkGecommentarieerd Geneesmiddelen Repertorium / Gent [Belgium] : Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI) = Centre Belge d'Information Pharmacothérapeutique (CBIP) (2018)
PermalinkGecommentarieerd Geneesmiddelen Repertorium / Gent [Belgium] : Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI) = Centre Belge d'Information Pharmacothérapeutique (CBIP) (2008)
PermalinkGecommentarieerd Geneesmiddelen Repertorium / Gent [Belgium] : Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI) = Centre Belge d'Information Pharmacothérapeutique (CBIP) (2009)
PermalinkGecommentarieerd Geneesmiddelen Repertorium / Gent [Belgium] : Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI) = Centre Belge d'Information Pharmacothérapeutique (CBIP) (2011)
PermalinkGecommentarieerd Geneesmiddelen Repertorium / Gent [Belgium] : Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI) = Centre Belge d'Information Pharmacothérapeutique (CBIP) (2010)
PermalinkGecommentarieerd Geneesmiddelen Repertorium / Gent [Belgium] : Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI) = Centre Belge d'Information Pharmacothérapeutique (CBIP) (2011)
PermalinkGeneesmiddelenformularium / Bruxelles [Belgique] : FOD Justitie = SPF Justice (2014)
PermalinkGenen en gezondheid / Peter Raeymaekers / Amsterdam [NL] : Wetenschappelijke Bibliotheek van Natuur & Techniek (2001)
PermalinkGeneralized linear models / Peter Mccullagh / London : Chapman & Hall (cop. 1998)
PermalinkGenetics and analysis of quantitative traits / Michael Lynch / Sunderland, Mass. : Sinauer (1998)
PermalinkPermalinkGetting Started with Entreprise Guide Software [texte imprimé] / Jawna Gardner / Cary, NC [United States] : SAS Institute (2003)
PermalinkGetting started with Stata / College Station, Tex. : Stata Press (2005)
Permalinkggplot2 / Hadley Wickham / Berlin : Springer (2016)
PermalinkGNP / Paris : OVP Editions du Vidal (2001)
Permalink